Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $252.33 in the prior trading day, Labcorp Holdings Inc (NYSE: LH) closed at $253.96, up 0.65%. In other words, the price has increased by $0.65 from its previous closing price. On the day, 1.39 million shares were traded. LH stock price reached its highest trading level at $256.48 during the session, while it also had its lowest trading level at $249.495.
Ratios:
Our goal is to gain a better understanding of LH by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 35.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.28. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.67.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 31 ’25 when Parham Richelle P bought 7,009 shares for $254.28 per share.
van der Vaart Sandra D sold 3,903 shares of LH for $1,059,371 on Aug 13 ’25. The EVP, Chief Legal Officer now owns 2,274 shares after completing the transaction at $271.42 per share. On Aug 13 ’25, another insider, van der Vaart Sandra D, who serves as the Officer of the company, bought 3,903 shares for $271.42 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 21078679552 and an Enterprise Value of 27054583808. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.94, and their Forward P/E ratio for the next fiscal year is 14.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.53 while its Price-to-Book (P/B) ratio in mrq is 2.42. Its current Enterprise Value per Revenue stands at 1.965 whereas that against EBITDA is 13.779.
Stock Price History:
The Beta on a monthly basis for LH is 0.91, which has changed by 0.11792934 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $293.72, while it has fallen to a 52-week low of $209.38. The 50-Day Moving Average of the stock is -8.26%, while the 200-Day Moving Average is calculated to be -0.51%.
Shares Statistics:
The stock has traded on average 575.40K shares per day over the past 3-months and 1077460 shares per day over the last 10 days, according to various share statistics. A total of 83.00M shares are outstanding, with a floating share count of 82.84M. Insiders hold about 0.32% of the company’s shares, while institutions hold 99.26% stake in the company. Shares short for LH as of 1760486400 were 2438588 with a Short Ratio of 4.24, compared to 1757894400 on 2495734. Therefore, it implies a Short% of Shares Outstanding of 2438588 and a Short% of Float of 3.82.
Dividends & Splits
In the trailing 12 months, LH’s forward annual dividend rate was 2.88, compared to 2.88 this year. Against a Trailing Annual Dividend Yield of 0.011413625. The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-08-28 with an ex-dividend date of 2025-11-26. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
Earnings Estimates
The stock of Labcorp Holdings Inc (LH) is currently being evaluated by 14.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $4.11, with high estimates of $4.3 and low estimates of $3.98.
Analysts are recommending an EPS of between $16.41 and $16.16 for the fiscal current year, implying an average EPS of $16.32. EPS for the following year is $17.55, with 19.0 analysts recommending between $18.08 and $16.86.
Revenue Estimates
12 analysts predict $3.57B in revenue for . The current quarter. It ranges from a high estimate of $3.61B to a low estimate of $3.54B. As of . The current estimate, Labcorp Holdings Inc’s year-ago sales were $3.33BFor the next quarter, 12 analysts are estimating revenue of $3.5B. There is a high estimate of $3.54B for the next quarter, whereas the lowest estimate is $3.46B.
A total of 17 analysts have provided revenue estimates for LH’s current fiscal year. The highest revenue estimate was $14.04B, while the lowest revenue estimate was $13.96B, resulting in an average revenue estimate of $14B. In the same quarter a year ago, actual revenue was $13.01BBased on 17 analysts’ estimates, the company’s revenue will be $14.61B in the next fiscal year. The high estimate is $14.88B and the low estimate is $14.4B.
